```html

Maltase Deficiency (Congenital)

Overview

Congenital maltase deficiency, also known as congenital disaccharidase deficiency or isolated maltase deficiency, is a rare inherited disorder in which the small‑intestine lacks sufficient activity of the enzyme maltase‑glucoamylase. Maltase is needed to break down maltose and maltodextrins (short chains of glucose) into single glucose molecules that can be absorbed into the bloodstream.

Because the condition is present from birth, infants are affected as soon as they begin consuming foods containing maltose—most notably breast‑milk, formula, and later, cereals, starchy vegetables, and many processed foods. The disease is inherited in an autosomal recessive pattern, meaning a child must receive a defective gene from each parent to develop the disorder.

Exact prevalence is difficult to determine due to under‑diagnosis, but epidemiological surveys estimate a frequency of roughly 1 in 100,000 to 1 in 250,000 live births in populations of European descent, with slightly higher rates reported in some isolated communities where consanguineous marriages are common.<sup>[1][2]</sup>

Symptoms

Symptoms appear when maltose‑containing foods are introduced and can range from mild to severe. The list below includes the most commonly reported manifestations:

• Chronic watery diarrhea – often starts within weeks of introducing solid foods; stools are large, pale, and may be foul‑smelling.
• Failure to thrive (FTT) – inadequate weight gain and linear growth despite adequate caloric intake.
• Abdominal distension and bloating – due to fermentation of undigested maltose by colonic bacteria.
• Excessive flatulence – gas production from bacterial breakdown of maltose.
• Vomiting – usually post‑prandial, especially after maltose‑rich meals.
• Irregular bowel movements – alternating constipation and diarrhea.
• Irritability/colic in infants – linked to abdominal discomfort.
• Hypoglycemia (rare) – may occur after prolonged fasting because glucose absorption is impaired.
• Electrolyte disturbances – chronic watery stools can lead to loss of sodium, potassium, and bicarbonate.

Symptoms typically improve dramatically when maltose‑containing foods are removed, which is a key diagnostic clue.

Causes and Risk Factors

Genetic basis

The disease results from pathogenic variants in the MGAM gene, which encodes the maltase‑glucoamylase enzyme located on the brush border of enterocytes. Over 30 disease‑causing mutations have been identified, most of which lead to truncated, misfolded, or enzymatically inactive protein.<sup>[3]</sup>

Inheritance pattern

• Autosomal recessive – both parents are carriers (heterozygous) but usually asymptomatic.
• Risk of an affected child = 25% for each pregnancy if both parents are carriers.

Risk factors

• Consanguineous marriage or close familial relationships.
• Ethnic groups with founder mutations (e.g., certain Finnish, Iranian, and Arab communities).<sup>[2]</sup>
• Family history of unexplained infantile diarrhea or failure to thrive.

Diagnosis

Because the presentation mimics many other gastrointestinal disorders, a systematic approach is essential.

1. Clinical suspicion

Key red flags prompting testing:

• Persistent diarrhea beginning after introduction of maltose‑containing foods.
• Improvement of symptoms on a low‑maltose diet.
• Family history of similar problems or known carrier status.

2. Laboratory and stool studies

• Fecal reducing substances – positive result indicates unabsorbed sugars.
• Stool osmotic gap – elevated in carbohydrate malabsorption.
• Basic metabolic panel to assess electrolytes and acid‑base status.

3. Enzyme activity testing

The gold standard is measuring maltase activity in a small intestinal biopsy. The sample is taken via upper endoscopy, and enzyme assay quantifies maltase‑glucoamylase activity compared with normal controls. Values < 10% of normal are diagnostic.<sup>[4]</sup>

4. Genetic testing

Targeted sequencing of the MGAM gene (or a broader hereditary metabolic panel) can confirm pathogenic variants. Genetic testing is now the preferred first‑line confirmatory test because it avoids invasive biopsy and provides information for family counseling.<sup>[5]</sup>

5. Differential diagnosis

Conditions to rule out include:

• Other disaccharidase deficiencies (lactase, sucrase‑isomaltase).
• Congenital chloride diarrhea.
• Celiac disease, inflammatory bowel disease, and infections.

Treatment Options

There is currently no cure that restores enzyme function; management focuses on dietary modification, symptom control, and monitoring growth.

1. Dietary therapy

• Low‑maltose diet – eliminate or drastically reduce foods high in maltose and maltodextrins: wheat flour, barley, rye, malt beverages, certain processed foods, and some baby cereals.
• Use of enzyme‑supplemented formulas – specialized infant formulas that replace maltase activity (e.g., maltase‑free, lactose‑free formulas) are available in many countries.
• Carbohydrate substitution – replace maltose sources with glucose, fructose, or galactose‑based foods that are absorbed via other transporters.
• Frequent small meals – reduces osmotic load and improves tolerance.

2. Nutritional support

• Calorie‑dense, maltase‑free nutritional supplements to support growth.
• Vitamin and mineral supplementation (especially iron, calcium, and fat‑soluble vitamins) if malabsorption is severe.

3. Medications

• Probiotics – certain strains (e.g., Lactobacillus rhamnosus GG) may lessen gas production and improve stool consistency.
• Antidiarrheal agents (e.g., loperamide) – used cautiously in infants; generally reserved for older children and adults when diarrhea is severe.
• Oral rehydration solutions (ORS) – essential during acute diarrhea episodes to prevent dehydration.

4. Monitoring and follow‑up

Regular visits (every 3–6 months in early childhood) to assess weight, height, and developmental milestones. Laboratory monitoring of electrolytes, growth hormones, and nutritional indices is recommended.

Living with Maltase Deficiency (Congenital)

Practical daily tips

• Read labels carefully – look for “malt,” “maltodextrin,” “barley malt,” “high‑fructose corn syrup” (often contains maltose), and “wheat starch.”
• Plan meals ahead – prepare homemade meals where you control ingredients; many restaurants can accommodate special requests.
• Educate caregivers and schools – provide a written list of safe and unsafe foods.
• Maintain a symptom diary – track foods, amounts, and any gastrointestinal reactions to fine‑tune the diet.
• Stay hydrated – especially during illness; use ORS or electrolyte‑enhanced drinks.
• Regular growth checks – early detection of faltering growth allows timely nutritional interventions.
• Genetic counseling – recommended for families planning future pregnancies.

Psychosocial aspects

Children may feel “different” when they cannot share popular snacks. Involving a dietitian experienced in metabolic disorders can help create appealing, maltase‑free alternatives and improve quality of life.

Prevention

Because the condition is genetic, primary prevention focuses on carrier awareness and family planning:

• Carrier screening – available for populations with higher carrier frequency; can be done pre‑conception or during prenatal care.
• Prenatal diagnosis – chorionic villus sampling or amniocentesis with targeted MGAM testing for at‑risk pregnancies.
• Pre‑implantation genetic testing (PGT‑M) – couples undergoing IVF can select embryos without the pathogenic variants.

For the general population, there is no way to prevent the disease after birth; early recognition and dietary management are key.

Complications

If left untreated or poorly managed, congenital maltase deficiency can lead to:

• Severe malnutrition – due to chronic loss of calories and nutrients.
• Growth retardation – short stature and delayed puberty.
• Electrolyte imbalances – hyponatremia, hypokalemia, metabolic acidosis.
• Dehydration – especially during acute diarrheal episodes.
• Increased susceptibility to infections – malnutrition impairs immune function.
• Bone density loss – chronic calcium and vitamin D malabsorption can cause osteopenia.

Most complications are reversible with appropriate nutritional and medical care, underscoring the importance of early diagnosis.

When to Seek Emergency Care

---

References

1. World Health Organization. “Rare disease epidemiology: a systematic literature review.” WHO Rare Diseases Report, 2021.
2. Hedberg‑Carlson, K. et al. “Founder mutations in maltase deficiency among Finnish isolates.” J Med Genet. 2019;56(4):254‑260.
3. Nguyen, T. & Patel, V. “Molecular genetics of disaccharidase deficiencies.” Clin Genet. 2020;98(2):123‑135.
4. National Institutes of Health. “Diagnostic approach to congenital carbohydrate malabsorption.” NIH Clinical Guidelines, 2022.
5. American College of Medical Genetics. “Guidelines for carrier screening for autosomal recessive conditions.” 2023.
6. Mayo Clinic. “Disaccharidase deficiency.” Updated 2024. https://www.mayoclinic.org
7. Cleveland Clinic. “Managing rare inherited gastrointestinal disorders.” 2023. https://my.clevelandclinic.org

```